- Home
- SINT vs IMRN Comparison
SINT vs IMRN Comparison
Compare SINT & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- IMRN
- Stock Information
- Founded
- SINT 1996
- IMRN 1994
- Country
- SINT United States
- IMRN Australia
- Employees
- SINT 20
- IMRN N/A
- Industry
- SINT Medical/Dental Instruments
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- IMRN Health Care
- Exchange
- SINT Nasdaq
- IMRN Nasdaq
- Market Cap
- SINT 8.3M
- IMRN 9.2M
- IPO Year
- SINT 2014
- IMRN N/A
- Fundamental
- Price
- SINT $3.04
- IMRN $1.81
- Analyst Decision
- SINT Strong Buy
- IMRN Strong Buy
- Analyst Count
- SINT 1
- IMRN 1
- Target Price
- SINT $28.00
- IMRN $5.00
- AVG Volume (30 Days)
- SINT 65.3K
- IMRN 82.1K
- Earning Date
- SINT 08-14-2025
- IMRN 09-08-2025
- Dividend Yield
- SINT N/A
- IMRN N/A
- EPS Growth
- SINT N/A
- IMRN N/A
- EPS
- SINT N/A
- IMRN N/A
- Revenue
- SINT $1,861,000.00
- IMRN $4,048,286.00
- Revenue This Year
- SINT N/A
- IMRN N/A
- Revenue Next Year
- SINT $87.50
- IMRN N/A
- P/E Ratio
- SINT N/A
- IMRN N/A
- Revenue Growth
- SINT N/A
- IMRN 82.90
- 52 Week Low
- SINT $1.71
- IMRN $1.50
- 52 Week High
- SINT $8.60
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- SINT 58.68
- IMRN 58.51
- Support Level
- SINT $2.85
- IMRN $1.62
- Resistance Level
- SINT $3.13
- IMRN $1.84
- Average True Range (ATR)
- SINT 0.19
- IMRN 0.09
- MACD
- SINT 0.06
- IMRN 0.02
- Stochastic Oscillator
- SINT 89.02
- IMRN 89.55
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.